{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:55:24Z","timestamp":1782186924729,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["MOP-119342"],"award-info":[{"award-number":["MOP-119342"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1317-3","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T20:49:52Z","timestamp":1462481392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria"],"prefix":"10.1186","volume":"15","author":[{"given":"Neda","family":"Moradin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mifong","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Hawari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Vandercruyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"De Spiegeleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"issue":"Suppl 1","key":"1317_CR1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1475-2875-8-S1-S2","volume":"8","author":"G Kokwaro","year":"2009","unstructured":"Kokwaro G. Ongoing challenges in the management of malaria. Malar J. 2009;8(Suppl 1):S2.","journal-title":"Malar J"},{"key":"1317_CR2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","volume":"118","author":"BM Greenwood","year":"2008","unstructured":"Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118:1266\u201376.","journal-title":"J Clin Invest"},{"key":"1317_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneurol.2009.23","volume":"5","author":"SK Mishra","year":"2009","unstructured":"Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol. 2009;5:189\u201398.","journal-title":"Nat Rev Neurol"},{"key":"1317_CR4","doi-asserted-by":"crossref","unstructured":"Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009;(3):CD007483. doi: 10.1002\/14651858.CD007483.pub2 .","DOI":"10.1002\/14651858.CD007483.pub2"},{"key":"1317_CR5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","volume":"7","author":"RT Eastman","year":"2009","unstructured":"Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864\u201374.","journal-title":"Nat Rev Microbiol"},{"key":"1317_CR6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"NJ White","year":"2008","unstructured":"White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330\u20134.","journal-title":"Science"},{"key":"1317_CR7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2385","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272\u201380.","journal-title":"Nat Rev Microbiol"},{"key":"1317_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"1317_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis"},{"key":"1317_CR10","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"1317_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pt.2013.04.001","volume":"29","author":"S Krishna","year":"2013","unstructured":"Krishna S, Kremsner PG. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol. 2013;29:313\u20137.","journal-title":"Trends Parasitol"},{"key":"1317_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.1215966","volume":"336","author":"IH Cheeseman","year":"2012","unstructured":"Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, et al. A major genome region underlying artemisinin resistance in malaria. Science. 2012;336:79\u201382.","journal-title":"Science"},{"key":"1317_CR13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"},{"key":"1317_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"1317_CR15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"1317_CR16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","volume":"347","author":"S Mok","year":"2015","unstructured":"Mok S, Ashley EA, Ferreira PE, Zhu L, Lin Z, Yeo T, et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science. 2015;347:431\u20135.","journal-title":"Science"},{"key":"1317_CR17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pt.2009.05.012","volume":"25","author":"SE Bongfen","year":"2009","unstructured":"Bongfen SE, Laroque A, Berghout J, Gros P. Genetic and genomic analyses of host-pathogen interactions in malaria. Trends Parasitol. 2009;25:417\u201322.","journal-title":"Trends Parasitol"},{"key":"1317_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOH.0000000000000039","volume":"21","author":"SM Taylor","year":"2014","unstructured":"Taylor SM, Fairhurst RM. Malaria parasites and red cell variants: when a house is not a home. Curr Opin Hematol. 2014;21:193\u2013200.","journal-title":"Curr Opin Hematol"},{"key":"1317_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.coi.2009.04.001","volume":"21","author":"AC Allison","year":"2009","unstructured":"Allison AC. Genetic control of resistance to human malaria. Curr Opin Immunol. 2009;21:499\u2013505.","journal-title":"Curr Opin Immunol"},{"key":"1317_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010581","volume":"8","author":"TJ Lamb","year":"2006","unstructured":"Lamb TJ, Brown DE, Potocnik AJ, Langhorne J. Insights into the immunopathogenesis of malaria using mouse models. Expert Rev Mol Med. 2006;8:1\u201322.","journal-title":"Expert Rev Mol Med"},{"key":"1317_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00335-010-9302-6","volume":"22","author":"R Longley","year":"2011","unstructured":"Longley R, Smith C, Fortin A, Berghout J, McMorran B, Burgio G, et al. Host resistance to malaria: using mouse models to explore the host response. Mamm Genome. 2011;22:32\u201342.","journal-title":"Mamm Genome"},{"key":"1317_CR22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood-2014-04-567149","volume":"125","author":"CM Smith","year":"2015","unstructured":"Smith CM, Jerkovic A, Puy H, Winship I, Deybach JC, Gouya L, et al. Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites. Blood. 2015;125:534\u201341.","journal-title":"Blood"},{"key":"1317_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1084\/jem.20061252","volume":"204","author":"G Min-Oo","year":"2007","unstructured":"Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med. 2007;204:511\u201324.","journal-title":"J Exp Med"},{"key":"1317_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.exppara.2010.02.009","volume":"125","author":"G Min-Oo","year":"2010","unstructured":"Min-Oo G, Ayi K, Bongfen SE, Tam M, Radovanovic I, Gauthier S, et al. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium. Exp Parasitol. 2010;125:315\u201324.","journal-title":"Exp Parasitol"},{"key":"1317_CR25","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1517\/14656566.5.11.2255","volume":"5","author":"R Kleta","year":"2004","unstructured":"Kleta R, Gahl WA. Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother. 2004;5:2255\u201362.","journal-title":"Expert Opin Pharmacother"},{"key":"1317_CR26","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.01719-09","volume":"54","author":"G Min-Oo","year":"2010","unstructured":"Min-Oo G, Fortin A, Poulin JF, Gros P. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Antimicrob Agents Chemother. 2010;54:3262\u201370.","journal-title":"Antimicrob Agents Chemother"},{"key":"1317_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/gene.2011.67","volume":"13","author":"A Laroque","year":"2012","unstructured":"Laroque A, Min-Oo G, Tam M, Radovanovic I, Stevenson MM, Gros P. Genetic control of susceptibility to infection with Plasmodium chabaudi chabaudi AS in inbred mouse strains. Genes Immun. 2012;13:155\u201363.","journal-title":"Genes Immun"},{"key":"1317_CR28","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1073\/pnas.191288998","volume":"98","author":"A Fortin","year":"2001","unstructured":"Fortin A, Cardon LR, Tam M, Skamene E, Stevenson MM, Gros P. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc Natl Acad Sci USA. 2001;98:10793\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1317_CR29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/IAI.02586-14","volume":"83","author":"S Torre","year":"2015","unstructured":"Torre S, Faucher SP, Fodil N, Bongfen SE, Berghout J, Schwartzentruber JA, et al. THEMIS is required for pathogenesis of cerebral malaria and protection against pulmonary tuberculosis. Infect Immun. 2015;83:759\u201368.","journal-title":"Infect Immun"},{"key":"1317_CR30","doi-asserted-by":"crossref","first-page":"e1003491","DOI":"10.1371\/journal.ppat.1003491","volume":"9","author":"J Berghout","year":"2013","unstructured":"Berghout J, Langlais D, Radovanovic I, Tam M, MacMicking JD, Stevenson MM, Gros P. Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog. 2013;9:e1003491.","journal-title":"PLoS Pathog"},{"key":"1317_CR31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/gene.2009.79","volume":"11","author":"J Berghout","year":"2010","unstructured":"Berghout J, Min-Oo G, Tam M, Gauthier S, Stevenson MM, Gros P. Identification of a novel cerebral malaria susceptibility locus (Berr5) on mouse chromosome 19. Genes Immun. 2010;11:310\u20138.","journal-title":"Genes Immun"},{"key":"1317_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-11-217","volume":"11","author":"NX Thanh","year":"2012","unstructured":"Thanh NX, Trung TN, Phong NC, Quang HH, Dai B, Shanks GD, et al. The efficacy and tolerability of artemisinin-piperaquine (Artequick(R)) versus artesunate-amodiaquine (Coarsucam) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam. Malar J. 2012;11:217.","journal-title":"Malar J"},{"key":"1317_CR33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0001-706X(03)00118-9","volume":"87","author":"BM Kotecka","year":"2003","unstructured":"Kotecka BM, Rieckmann KH, Davis TM, Batty KT, Ilett KF. Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma. Acta Trop. 2003;87:371\u20135.","journal-title":"Acta Trop"},{"key":"1317_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0378-4347(95)00428-9","volume":"677","author":"KT Batty","year":"1996","unstructured":"Batty KT, Davis TM, Thu LT, Binh TQ, Anh TK, Ilett KF. Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria. J Chromatogr B Biomed Appl. 1996;677:345\u201350.","journal-title":"J Chromatogr B Biomed Appl"},{"key":"1317_CR35","unstructured":"www.drugs.com\/pro\/cystagon . Accessed 10 Apr 2016."},{"issue":"3","key":"1317_CR36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00436-014-3804-1","volume":"113","author":"MB Isah","year":"2014","unstructured":"Isah MB, Ibrahim MA. The role of antioxidants treatment on the pathogenesis of malarial infections: a review. Parasitol Res. 2014;113(3):801\u20139.","journal-title":"Parasitol Res"},{"key":"1317_CR37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkt486","volume":"69","author":"T Antoine","year":"2014","unstructured":"Antoine T, Fisher N, Amewu R, O\u2019Neill PM, Ward SA, Biagini GA. Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential. J Antimicrob Chemother. 2014;69:1005\u201316.","journal-title":"J Antimicrob Chemother"},{"key":"1317_CR38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","volume":"40","author":"T Efferth","year":"2010","unstructured":"Efferth T, Kaina B. Toxicity of the antimalarial artemisinin and its dervatives. Crit Rev Toxicol. 2010;40:405\u201321.","journal-title":"Crit Rev Toxicol"},{"key":"1317_CR39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2125.2010.03721.x","volume":"70","author":"JA Gangoiti","year":"2010","unstructured":"Gangoiti JA, Fidler M, Cabrera BL, Schneider JA, Barshop BA, Dohil R. Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study. Br J Clin Pharmacol. 2010;70:376\u201382.","journal-title":"Br J Clin Pharmacol"},{"key":"1317_CR40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1365-2125.2003.01927.x","volume":"56","author":"EB Belldina","year":"2003","unstructured":"Belldina EB, Huang MY, Schneider JA, Brundage RC, Tracy TS. Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients. Br J Clin Pharmacol. 2003;56:520\u20135.","journal-title":"Br J Clin Pharmacol"},{"issue":"71\u201375","key":"1317_CR41","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jpeds.2009.07.016","volume":"156","author":"R Dohil","year":"2010","unstructured":"Dohil R, Fidler M, Gangoiti JA, Kaskel F, Schneider JA, Barshop BA. Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr. 2010;156(71\u201375):e71\u20133.","journal-title":"J Pediatr"},{"key":"1317_CR42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2125.2006.02734.x","volume":"63","author":"MC Fidler","year":"2007","unstructured":"Fidler MC, Barshop BA, Gangoiti JA, Deutsch R, Martin M, Schneider JA, et al. Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion. Br J Clin Pharmacol. 2007;63:36\u201340.","journal-title":"Br J Clin Pharmacol"},{"key":"1317_CR43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbrc.2004.11.051","volume":"326","author":"RC Reddy","year":"2005","unstructured":"Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326:472\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"1317_CR44","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.bmc.2007.12.054","volume":"16","author":"S Mishra","year":"2008","unstructured":"Mishra S, Karmodiya K, Surolia N, Surolia A. Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorg Med Chem. 2008;16:2894\u2013902.","journal-title":"Bioorg Med Chem"},{"key":"1317_CR45","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4269\/ajtmh.14-0553","volume":"92","author":"AM Stickles","year":"2015","unstructured":"Stickles AM, Ting LM, Morrisey JM, Li Y, Mather MW, Meermeier E, et al. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy. Am J Trop Med Hyg. 2015;92:1195\u2013201.","journal-title":"Am J Trop Med Hyg"},{"key":"1317_CR46","doi-asserted-by":"crossref","first-page":"177ra37","DOI":"10.1126\/scitranslmed.3005029","volume":"5","author":"A Nilsen","year":"2013","unstructured":"Nilsen A, LaCrue AN, White KL, Forquer IP, Cross RM, Marfurt J, et al. Quinolone-3-diarylethers: a new class of antimalarial drug. Sci Transl Med. 2013;5:177ra37.","journal-title":"Sci Transl Med"},{"key":"1317_CR47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1128\/AAC.04419-14","volume":"59","author":"NA Malmquist","year":"2015","unstructured":"Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, et al. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. Antimicrob Agents Chemother. 2015;59:950\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1317_CR48","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/AAC.01175-08","volume":"53","author":"PN Soh","year":"2009","unstructured":"Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez MC, Berry A, et al. In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother. 2009;53:1100\u20136.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1317-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:08:23Z","timestamp":1567836503000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1317-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1317-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]},"article-number":"260"}}